(2026). Longitudinal changes in DTI‐ALPS and choroid plexus volume relative to CSF biomarkers during lecanemab treatment in mild cognitive impairment: A pilot study. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Longitudinal Changes in DTI‐ALPS and Choroid Plexus Volume Relative to CSF Biomarkers During Lecanemab Treatment in Mild Cognitive Impairment: A Pilot Study."
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Longitudinal Changes in DTI‐ALPS and Choroid Plexus Volume Relative to CSF Biomarkers During Lecanemab Treatment in Mild Cognitive Impairment: A Pilot Study."
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.